Skip to content
pyrilamine

Structure via PubChem · Public domain (PubChem)

EntityQ3800087· pop 17· linked from 980 articles

pyrilamine

Sign in to save

Also known as Anthisan®, mepiramine, mepyramine maleate, pyrilamine tannate, Pyrlex®, N',N'-dimethyl-N-(p-methoxybenzyl)-N-(2-pyridyl)ethylenediamine, N-(p-methoxybenzyl)-N',N'-dimethyl-N-(alpha-pyridyl)ethylenediamine

Mepyramine, also known as pyrilamine, is a first-generation antihistamine, targeting the H1 receptor as an inverse agonist. Mepyramine rapidly permeates the brain, often causing drowsiness.

Chemical data

Formula
C17H23N3O
Molecular weight
285.4 g/mol
IUPAC name
N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine
SMILES
CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2
InChIKey
YECBIJXISLIIDS-UHFFFAOYSA-N
XLogP
3.3
Polar surface area
28.6 Ų
H-bond donors
0
H-bond acceptors
4
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
1973
Admin. routes
oral, topical
Indications
Pruritus, allergic disease

via ChEMBL · EBI

Research

2,541 papers

via PubMed

Wikidata facts

Mass
285.184112
Has use
medication
Show 5 more facts
chemical formula
C₁₇H₂₃N₃O
canonical SMILES
CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2
subject has role
hypnotic
physically interacts with
Histamine receptor H1
Commons category
Mepyramine
Sources (3)

via Wikidata · CC0

~2 min read

Encyclopedic overview

2 sections
Contents
  • See also
  • References

Mepyramine, also known as pyrilamine, is a first-generation antihistamine, targeting the H1 receptor as an inverse agonist. Mepyramine rapidly permeates the brain, often causing drowsiness. It is often sold as a maleate salt, pyrilamine maleate.

The medication has negligible anticholinergic activity, with 130,000-fold selectivity for the histamine H1 receptor over the muscarinic acetylcholine receptors (for comparison, diphenhydramine had 20-fold selectivity for the H1 receptor).

Excerpted from Wikipedia’s “pyrilamine” article, available under the CC BY-SA 4.0 licence.